Disorders of Puberty

  • Dennis M. Styne
Chapter

Abstract

Puberty should not be considered as a single event but rather a process in which the hypothalamic pituitary gonadal axis develops from the infantile stage to maturity. This is just one part of the continuum of reproductive function that begins during fetal life and ends in senescence. The age of puberty is, in large degree, determined by genetic factors as 50–80 % of pubertal timing is determined by genetic factors but environmental factors can alter this target. The increasing prevalence of obesity has been one factor postulated to decrease the age of menarche in recent years.

Keywords

Leydig Cell Polycystic Ovarian Syndrome Turner Syndrome Pubertal Development Precocious Puberty 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Suggested Readings

  1. 1.
    Main KM, Skakkebaek NE, Toppari J. Cryptorchidism as part of the testicular dysgenesis syndrome: the environmental connection. Endocr Dev. 2009;14:167–73.CrossRefPubMedGoogle Scholar
  2. 2.
    Teo AQ, Khan AR, Williams MP, Carroll D, Hughes IA. Is surgical exploration necessary in bilateral anorchia? J Pediatr Urol. 2013;9(1):e78–81.CrossRefPubMedGoogle Scholar
  3. 3.
    Rivkees SA, Hager K, Hosono S, Wise A, Li P, Rinder HM, Gruen JR. A highly sensitive, high-throughput assay for the detection of Turner syndrome. J Clin Endocrinol Metab. 2011;96(3):699–705.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Bondy CA, Turner Syndrome Study Group. Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab. 2007;92(1):10–25.CrossRefPubMedGoogle Scholar
  5. 5.
    Mauras N. Strategies for maximizing growth in puberty in children with short stature. Pediatr Clin North Am. 2011;58(5):1167–79. x.CrossRefPubMedGoogle Scholar
  6. 6.
    Keil MF, Stratakis CA. Pituitary tumors in childhood: update of diagnosis, treatment and molecular genetics. Expert Rev Neurother. 2008;8(4):563–74.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Palmert MR, Dunkel L, Witchel SF. Chapter 17—Puberty and its disorders in the male. In: Sperling MA, editor. Pediatric endocrinology. 4th ed. Philadelphia, PA: Elsevier; 2014. p. 697–733.Google Scholar
  8. 8.
    Saenger P, Bondy CA. Chapter 16—Turner syndrome. In: Sperling MA, editor. Pediatric endocrinology. 4th ed. Philadelphia, PA: Elsevier; 2014. p. 664–696.Google Scholar
  9. 9.
    Rosenfield RL, Cooke DW, Radovick S. Chapter 15—Puberty and its disorders in the female. In: Sperling MA, editor. Pediatric endocrinology. 4th ed. Philadelphia, PA: Elsevier; 2014. p. 569–663.Google Scholar
  10. 10.
    Terasawa E, Guerriero KA, Plant TM. Kisspeptin and puberty in mammals. Adv Exp Med Biol. 2013;784:253–73.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Palmert MR, Dunkel L. Clinical practice. Delayed puberty. N Engl J Med. 2012;366(5):443–53.CrossRefPubMedGoogle Scholar
  12. 12.
    Harrington J, Palmert MR. Clinical review: Distinguishing constitutional delay of growth and puberty from isolated hypogonadotropic hypogonadism: critical appraisal of available diagnostic tests. J Clin Endocrinol Metab. 2012;97(9):3056–67.CrossRefPubMedGoogle Scholar
  13. 13.
    Henrichs KL, McCauley HL, Miller E, Styne DM, Saito N, Breslau J. Early menarche and childhood adversities in a nationally representative sample. Int J Pediatr Endocrinol. 2014;2014(1):14.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Lee Y, Styne D. Influences on the onset and tempo of puberty in human beings and implications for adolescent psychological development. Horm Behav. 2013;64(2):250–61.CrossRefPubMedGoogle Scholar
  15. 15.
    Loomba-Albrecht LA, Styne DM. Effect of puberty on body composition. Curr Opin Endocrinol Diabetes Obes. 2009;16(1):10–5.CrossRefPubMedGoogle Scholar
  16. 16.
    Carel JC, Eugster EA, Rogol A, Ghizzoni L, Palmert MR, Antoniazzi F, Berenbaum S, Bourguignon JP, Chrousos GP, Coste J, Deal S, De Vries L, Foster C, Heger S, Holland J, Jahnukainen K, Juul A, Kaplowitz P, Lahlou N, Lee MM, Lee P, Merke DP, Neely EK, Oostdijk W, Phillip M, Rosenfield RL, Shulman D, Styne D, Tauber M, Wit JM. Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics. 2009;123(4):e752–62.CrossRefPubMedGoogle Scholar
  17. 17.
    Albrecht L, Styne D. Laboratory testing of gonadal steroids in children. Pediatr Endocrinol Rev. 2007;5 Suppl 1:599–607.PubMedGoogle Scholar
  18. 18.
    Lenz AM, Shulman D, Eugster EA, Rahhal S, Fuqua JS, Pescovitz OH, Lewis KA. Bicalutamide and third-generation aromatase inhibitors in testotoxicosis. Pediatrics. 2010;126(3):e728–33.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Shulman DI, Francis GL, Palmert MR, Eugster EA. Use of aromatase inhibitors in children and adolescents with disorders of growth and adolescent development. Pediatrics. 2008;121(4):e975–83.CrossRefPubMedGoogle Scholar
  20. 20.
    Rosenthal SM. Approach to the patient: transgender youth: endocrine considerations. J Clin Endocrinol Metab. 2014;99(12):4379–89. doi: 10.1210/jc20141919.CrossRefPubMedGoogle Scholar
  21. 21.
    Waimey KE, Duncan FE, Su HI, Smith K, Wallach H, Jona K, Coutifaris C, Gracia CR, Shea LD, Brannigan RE, Chang RJ, Zelinski MB, Stouffer RL, Taylor RL, Woodruff TK. Future directions in oncofertility and fertility preservation: a report from the 2011 Oncofertility Consortium Conference. J Adolesc Young Adult Oncol. 2013;2(1):25–30.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK, Endocrine Society. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565–92.CrossRefPubMedGoogle Scholar
  23. 23.
    Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981–1030.CrossRefPubMedGoogle Scholar
  24. 24.
    Fuqua JS. Treatment and outcomes of precocious puberty: an update. J Clin Endocrinol Metab. 2013;98(6):2198–207.CrossRefPubMedGoogle Scholar
  25. 25.
    Mountjoy M, Sundgot-Borgen J, Burke L, Carter S, Constantini N, Lebrun C, Meyer N, Sherman R, Steffen K, Budgett R, Ljungqvist A. The IOC consensus statement: beyond the Female Athlete Triad–Relative Energy Deficiency in Sport (RED-S). Br J Sports Med. 2014;48(7):491–7.CrossRefPubMedGoogle Scholar
  26. 26.
    Rosenfield RL. Hirsutism and the variable response of the pilosebaceous unit to androgen. J Investig Dermatol Symp Proc. 2005;10(3):205–8.CrossRefPubMedGoogle Scholar
  27. 27.
    Rosenfield RL. Clinical review: Adolescent anovulation: maturational mechanisms and implications. J Clin Endocrinol Metab. 2013;98(9):3572–83.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Voutilainen R, Jaaskelainen J. Premature adrenarche: etiology, clinical findings, and consequences. J Steroid Biochem Mol Biol. 2015;145:226–36.CrossRefPubMedGoogle Scholar
  29. 29.
    Styne D. Puberty. In: Gardner DG, Shoback D, editors. Greenspan’s basic & clinical endocrinology. 9th ed. New York: The McGraw-Hill Companies, Inc.; 2011.Google Scholar
  30. 30.
    Styne DM, Grumbach MM. Puberty: ontogeny, neuroendocrinology, physiology, and disorders. In: Williams RH, Melmed S, editors. Williams textbook of endocrinology. Philadelphia, PA: Elsevier; 2015.Google Scholar
  31. 31.
    Finlayson CA, Styne DM, Larry Jameson J. Endocrinology of sexual maturation and puberty. In: Larry Jameson J, De Groot LJ, editors. Endocrinology: adult and pediatric. 7th ed. Philadelphia, PA: Elsevier; 2015.Google Scholar
  32. 32.
    Abreu AP et al. Central precocious puberty caused by mutations in the imprinted gene MKRN3. N Engl J Med. 2013;368(26):2467–75.2.Google Scholar
  33. 33.
    Latronico AC, Brito VN, Carel JC. Causes, diagnosis, and treatment of central precocious puberty. Lancet Diabetes Endocrinol. 2016. pii: S2213–8587(15)00380–0.Google Scholar
  34. 34.
    Gore AC et al. Executive summary to EDC-2: The endocrine society’s second scientific statement on endocrine-disrupting chemicals. Endocr Rev. 2015;36(6):593–602.Google Scholar
  35. 35.
    Lee JM, Wasserman R, Kaciroti N, Gebremariam A, Steffes J, Dowshen S, Harris D, Serwint J, Abney D, Smitherman L, Reiter E, Herman-Giddens ME. Timing of puberty in overweight versus obese boys. Pediatrics. 2016. pii: peds. 2015–0164.Google Scholar
  36. 36.
    Biro FM, Chan Y. Normal puberty. http://www.uptodate.com/contents/normal-puberty.
  37. 37.
    Harrington J, Palmert MR. Definition, etiology, and evaluation of precocious puberty. http://www.uptodate.com/contents/definition-etiology-and-evaluation-of-precocious-puberty.
  38. 38.
    Harrington J, Palmert MR. Treatment of precocious puberty. http://www.uptodate.com/contents/treatment-of-precocious-puberty.
  39. 39.
    Crowley WF, Pitteloud N. Diagnosis and treatment of delayed puberty. http://www.uptodate.com/contents/diagnosis-and-treatment-of-delayed-puberty.
  40. 40.
    Rosenfield RL. Premature adrenarche. http://www.uptodate.com/contents/premature-adrenarche.

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  • Dennis M. Styne
    • 1
  1. 1.University of California Davis School of MedicineSacramentoUSA

Personalised recommendations